APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Asthma Drugs Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchAsthma Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Asthma Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Drugs include Teva Pharmaceutical, Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Vectura Group and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Asthma Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Asthma Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Asthma Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Asthma Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Asthma Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Asthma Drugs Market by Company

Teva Pharmaceutical

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

AstraZeneca

Vectura Group

Boehringer Ingelheim

Asthma Drugs Segment by Type

Quick-relief Medications (Rescue Medications)

Medications for Allergy-induced Asthma

Asthma Drugs Segment by Application

Allergic Asthma

Non-Allergic Asthma

Asthma Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Quick-relief Medications (Rescue Medications) Table 2. Major Company of Medications for Allergy-induced Asthma Table 3. Global Asthma Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Asthma Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Asthma Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Asthma Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Asthma Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Asthma Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Asthma Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Asthma Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Asthma Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Asthma Drugs Industry Trends Table 25. Asthma Drugs Industry Drivers Table 26. Asthma Drugs Industry Opportunities and Challenges Table 27. Asthma Drugs Industry Restraints Table 28. Global Asthma Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Asthma Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Asthma Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Asthma Drugs Sales Share by Company (2021-2026) Table 32. Global Asthma Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Asthma Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Asthma Drugs Major Company Production Sites and Headquarters Table 35. Global Asthma Drugs Company, Product Type & Application Table 36. Global Asthma Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Asthma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Asthma Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Asthma Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Asthma Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Asthma Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Asthma Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Asthma Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Asthma Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Asthma Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Asthma Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Asthma Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Asthma Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Asthma Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Asthma Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Asthma Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Asthma Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Asthma Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Asthma Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Asthma Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceutical Company Information Table 72. Teva Pharmaceutical Business Overview Table 73. Teva Pharmaceutical Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Asthma Drugs Product Portfolio Table 75. Teva Pharmaceutical Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novartis Asthma Drugs Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Asthma Drugs Product Portfolio Table 85. Merck Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Roche Asthma Drugs Product Portfolio Table 90. Roche Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Asthma Drugs Product Portfolio Table 95. Pfizer Recent Development Table 96. GlaxoSmithKline Company Information Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GlaxoSmithKline Asthma Drugs Product Portfolio Table 100. GlaxoSmithKline Recent Development Table 101. AstraZeneca Company Information Table 102. AstraZeneca Business Overview Table 103. AstraZeneca Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. AstraZeneca Asthma Drugs Product Portfolio Table 105. AstraZeneca Recent Development Table 106. Vectura Group Company Information Table 107. Vectura Group Business Overview Table 108. Vectura Group Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Vectura Group Asthma Drugs Product Portfolio Table 110. Vectura Group Recent Development Table 111. Boehringer Ingelheim Company Information Table 112. Boehringer Ingelheim Business Overview Table 113. Boehringer Ingelheim Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Boehringer Ingelheim Asthma Drugs Product Portfolio Table 115. Boehringer Ingelheim Recent Development Table 116. North America Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 118. North America Asthma Drugs Sales Market Share by Country (2021-2026) Table 119. North America Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Asthma Drugs Market Share by Country (2021-2026) Table 124. North America Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Asthma Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 128. Europe Asthma Drugs Sales Market Share by Country (2021-2026) Table 129. Europe Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Asthma Drugs Market Share by Country (2021-2026) Table 134. Europe Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Asthma Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Asthma Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Asthma Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Asthma Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 148. Latin America Asthma Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Asthma Drugs Market Share by Country (2021-2026) Table 154. Latin America Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Asthma Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Asthma Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Asthma Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Asthma Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Asthma Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Asthma Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Asthma Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Asthma Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa Asthma Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Asthma Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Asthma Drugs Distributors List Table 169. Asthma Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Asthma Drugs Image Figure 2. Global Asthma Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Drugs Sales (2021-2032) & (K Units) Figure 5. Quick-relief Medications (Rescue Medications) Image Figure 6. Global Quick-relief Medications (Rescue Medications) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Medications for Allergy-induced Asthma Image Figure 8. Global Medications for Allergy-induced Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Asthma Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Asthma Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Asthma Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Asthma Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Asthma Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Allergic Asthma Image Figure 24. Global Allergic Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 25. Non-Allergic Asthma Image Figure 26. Global Non-Allergic Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Asthma Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Asthma Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Asthma Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Asthma Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Asthma Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Asthma Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Asthma Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asthma Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Asthma Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Quick-relief Medications (Rescue Medications)
  • Medications for Allergy-induced Asthma
Applications
  • Allergic Asthma
  • Non-Allergic Asthma
Companies covered
  • Teva Pharmaceutical
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Vectura Group
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Asthma Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Asthma Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Asthma Drugs Market by Type
  6. 1.3.1 Quick-relief Medications (Rescue Medications)
  7. 1.3.2 Medications for Allergy-induced Asthma
  8. 1.4 Global Asthma Drugs Market Size by Type
  9. 1.4.1 Global Asthma Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Asthma Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Asthma Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Asthma Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Asthma Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Asthma Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Asthma Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Asthma Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Asthma Drugs Industry Trends
  2. 2.2 Asthma Drugs Industry Drivers
  3. 2.3 Asthma Drugs Industry Opportunities and Challenges
  4. 2.4 Asthma Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Asthma Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Asthma Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Asthma Drugs Price (2021-2026)
  4. 3.4 Global Asthma Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Asthma Drugs Company, Product Type & Application
  7. 3.7 Global Asthma Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Drugs Tier 1, Tier 2, and Tier 3
4 Asthma Drugs Regional Status and Outlook
  1. 4.1 Global Asthma Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Asthma Drugs Historic Market Size by Region
  3. 4.2.1 Global Asthma Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Asthma Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Asthma Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Asthma Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Asthma Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Asthma Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Asthma Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Asthma Drugs by Application
  1. 5.1 Asthma Drugs Market by Application
  2. 5.1.1 Allergic Asthma
  3. 5.1.2 Non-Allergic Asthma
  4. 5.2 Global Asthma Drugs Market Size by Application
  5. 5.2.1 Global Asthma Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Asthma Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Asthma Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Asthma Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Asthma Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Asthma Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Asthma Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Asthma Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Asthma Drugs Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Asthma Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Asthma Drugs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Asthma Drugs Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Asthma Drugs Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Asthma Drugs Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Asthma Drugs Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Vectura Group
  44. 6.8.1 Vectura Group Company Information
  45. 6.8.2 Vectura Group Business Overview
  46. 6.8.3 Vectura Group Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Vectura Group Asthma Drugs Product Portfolio
  48. 6.8.5 Vectura Group Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Asthma Drugs Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Asthma Drugs Sales by Country
  2. 7.1.1 North America Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Asthma Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Asthma Drugs Market Size by Country
  6. 7.2.1 North America Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Asthma Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Asthma Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Asthma Drugs Sales by Country
  2. 8.1.1 Europe Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Asthma Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Asthma Drugs Market Size by Country
  6. 8.2.1 Europe Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Asthma Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Asthma Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Asthma Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Asthma Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Asthma Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Asthma Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Asthma Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Asthma Drugs Sales by Country
  2. 10.1.1 South America Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Asthma Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Asthma Drugs Market Size by Country
  6. 10.2.1 South America Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Asthma Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Asthma Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Asthma Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Asthma Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Asthma Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Asthma Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Asthma Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Asthma Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Asthma Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Asthma Drugs Value Chain Analysis
  2. 12.1.1 Asthma Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Asthma Drugs Production Mode & Process
  7. 12.2 Asthma Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Asthma Drugs Distributors
  10. 12.2.3 Asthma Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst